Table 3.
Hazard Ratios of Factors Predicting Complete Resolution of PCRD in cCSC Patients
Characteristics | Univariate analysis* | Multivariate analysis* | ||
HR (95% CI) | P | HR (95% CI) | P | |
Male gender | 1.02 (0.36–2.86) | 0.967 | 1.16 (0.36–3.71) | 0.807 |
Caucasian ethnicity | 1.60 (0.70–3.65) | 0.262 | 0.39 (0.14–1.07) | 0.068 |
Steroid use | 1.08 (0.47–2.52) | 0.852 | 0.64 (0.22–1.88) | 0.420 |
SRF leakage at PCRD manifestation | 4.09 (1.23–13.54) | 0.021 | 2.47 (0.65–9.45) | 0.186 |
SRF leakage under PCRD | 0.46 (0.62–2.83) | 0.464 | 1.35 (0.52–3.56) | 0.540 |
Foveal location of PCRD | 2.24 (0.98–5.12) | 0.055 | 1.78 (0.73–4.32) | 0.205 |
DARA surface | 0.86 (0.77–0.96) | 0.005 | 0.90 (0.81–1.01) | 0.065 |
Age at cCSC diagnosis | 1.05 (1.02–1.09) | 0.004 | 1.05 (1.01–1.09) | 0.025 |
The overall model was statistically significant with a Chi-square P-value of 0.003.
DARA, diffuse atrophic RPE alteration.